Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Antihypertensive drug prazosin may also be effective for treating alcohol withdrawal symptoms

Staff Writer
Staff Writer 3 years ago
Updated 2021/05/12 at 6:34 PM
Share
SHARE

A commonly used antihypertensive drug once studied for the use of treating post-traumatic stress disorder could also be effective for alcohol withdrawal symptoms, a new study by Yale University determined.

According to their new findings, published in the American Journal of Psychiatry, the drug prazosin, used for the treatment of high blood pressure, may reduce the symptoms of alcohol withdrawal, which includes heightened cravings of alcohol, tremors, anxiety, and insomnia.

For the study, 100 participants with alcoholism were either administered the drug prazosin or a placebo. The participants exhibited symptoms of alcohol withdrawal as they were given either option of treatment for their condition.

By the end of the study, prazosin, consumed three times per day, was shown to drastically lessen the number of binge-drinking episodes among the patients in comparison to the other group.

“The findings indicate that alcohol withdrawal symptoms are a significant moderator of prazosin treatment response for alcohol use outcomes and for associated symptoms of alcohol craving, anxiety, and mood symptoms,” the results of the study read.

“These data support further evaluation of alcohol withdrawal symptoms as a prognostic indicator of prazosin’s efficacy in the treatment of alcohol use disorder.”

Given the lack of effective readily available treatments for severe withdrawal symptoms, the findings are promising and provide a new glimpse of hope for patients dealing with alcoholism.

The study was funded by the National Institute of Alcoholism and Alcohol Abuse, the Connecticut State Department of Mental Health and Addiction Services.

Photo: imgix.net

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

New study explores magic mushrooms for anorexia nervosa psychopathology

Staff Writer November 19, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Researchers fiddle with environmental DNA techniques to improve terrorism probes
Next Article America’s reputation on the world stage plummeted during the Trump era

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
Clinical

New study reveals positive results from postpartum depression treatment Zuranolone

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?